We first observed an enrichment of early NK cells (CD56+CD57−) (p < 0.001) (Figure S4A) in benign ovarian tumors compared to ovarian cancer, while late NK cell levels did not differ significantly (Figure S4B). Here, NCAM1 is linked to ovarian cancer.